Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
4.670
+0.080 (1.74%)
Nov 20, 2024, 4:00 PM EST - Market closed
Valneva SE Employees
Valneva SE had 676 employees as of December 31, 2023. The number of employees decreased by 43 or -5.98% compared to the previous year.
Employees
676
Change (1Y)
-43
Growth (1Y)
-5.98%
Revenue / Employee
$261,565
Profits / Employee
-$12,239
Market Cap
361.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Enhabit | 10,800 |
ZimVie | 2,600 |
Ginkgo Bioworks Holdings | 1,218 |
Amylyx Pharmaceuticals | 384 |
Verve Therapeutics | 255 |
Alector | 244 |
ProQR Therapeutics | 157 |
MaxCyte | 143 |
VALN News
- 5 days ago - European And US Vaccine Stocks Are Under Pressure - Here's WHy - Benzinga
- 7 days ago - Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2 - GlobeNewsWire
- 11 days ago - Valneva SE (VALN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 weeks ago - Valneva to Present on Chikungunya at Several Leading Scientific Conferences - GlobeNewsWire
- 5 weeks ago - Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V - GlobeNewsWire
- 6 weeks ago - Valneva Hosts Investor Day in New York City - GlobeNewsWire
- 7 weeks ago - Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ET - GlobeNewsWire